title: Perceptions and needs of women with metastatic breast cancer: a focus on clinical trials.
abstract: Many patients are living longer with Metastatic Breast Cancer (MBC) than ever before. However, complete responses remain uncommon, and progression of disease is often inevitable. The experience of living with MBC exposes patients to a wide variety of clinical, psychological, social and spiritual issues. Although much research effort has focused on decision-making and coping strategies among women with early breast cancer, relatively little attention has been given to the needs, experiences, and perceptions of women living with MBC. Furthermore, there are major research gaps in understanding and prioritizing the types of psycho-social interventions that would make the most difference in the lives of these patients. Fortunately, the tide is turning. This communication represents a joint effort of the Breast International Group and the National Cancer Institute (NCI)-sponsored North American Breast Cancer Group (BIG-NABCG) to highlight perceptions and needs of patients living with MBC and current obstacles facing them, and recommends strategies for better addressing some of these unmet needs.
authors.affiliation: Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine, 4800 Alberta Avenue, El Paso, TX 79905, United States. Zeina.nahleh@ttuhsc.edu
authors.forename: Zeina A
authors.initials: ZA
authors.lastname: Nahleh
authors.forename: Nancy U
authors.initials: NU
authors.lastname: Lin
authors.forename: Antonio C
authors.initials: AC
authors.lastname: Wolff
authors.forename: Fatima
authors.initials: F
authors.lastname: Cardoso
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology / Q000523:psychology*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D020380:Needs Assessment; D009362:Neoplasm Metastasis; D010353:Patient Education as Topic; D010358:Patient Participation; D010465:Perception
references.citation: J Natl Cancer Inst. 2011 Mar 2;103(5):384-97
references.pmid: 21317382
references.citation: Ann Oncol. 2010 Nov;21(11):2169-2174
references.pmid: 20427349
references.citation: J Clin Oncol. 2010 May 20;28(15):2635-40
references.pmid: 20406927
references.citation: Cancer. 2004 Jan 1;100(1):44-52
references.pmid: 14692023
references.citation: Breast. 2009 Oct;18(5):271-2
references.pmid: 19762241
references.citation: J Gen Intern Med. 2009 Nov;24 Suppl 2:S459-66
references.pmid: 19838851
references.citation: Semin Oncol Nurs. 2010 Aug;26(3):195-202
references.pmid: 20656143
references.citation: Cancer Treat Res. 2007;132:143-56
references.pmid: 17305020
references.citation: Trials. 2006 Apr 07;7:9
references.pmid: 16603070
references.citation: Breast. 2009 Oct;18(5):273-5
references.pmid: 19616435
references.citation: Breast J. 2000 Oct;6(5):310-314
references.pmid: 11348388
references.citation: Breast. 2012 Jun;21(3):242-52
references.pmid: 22425534
references.citation: J Clin Oncol. 2008 Jun 1;26(16):2666-73
references.pmid: 18509178
references.citation: Br J Cancer. 2000 Jun;82(11):1783-8
references.pmid: 10839291
references.citation: Eur J Cancer. 2006 Aug;42(12):1744-8
references.pmid: 16777404
references.citation: J Oncol Pract. 2011 Jul;7(4):267-70
references.pmid: 22043194
references.citation: J Natl Cancer Inst. 2011 Mar 2;103(5):357-8
references.pmid: 21317381